UK markets closed

Teijin Ltd (TIJ.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
9.00-0.05 (-0.55%)
At close: 08:11AM CEST
Full screen
Previous close9.05
Open9.00
Bid9.00 x 0
Ask9.15 x 0
Day's range9.00 - 9.00
52-week range7.55 - 10.20
Volume200
Avg. volume3
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Ascendis Pharma Announces Strategic Partnership with Teijin Limited in Japan

    – Teijin to receive exclusive license to further develop and commercialize TransCon™ hGH, TransCon™ PTH, and TransCon™ CNP in Japan – Ascendis Pharma is eligible to receive $70 million upfront, development/regulatory milestones of up to $175 million, transfer pricing, and commercial milestones – Ascendis Pharma is also eligible to receive royalties on net sales in Japan, of up to mid-20’s percent, varying by product COPENHAGEN, Denmark, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasd